Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Mr. Michael G. Campbell CPA

Chief Executive Officer, Chief Financial Officer & Principal Accounting Officer

Име	Заглавие
Mr. Michael G. Campbell CPA	Chief Executive Officer, Chief Financial Officer & Principal Accounting Officer
Ms. Janice Marie McCourt B.S., CLP, M.B.A., R.Ph.	Chief Business Officer
Dr. David Soane Ph.D.	Co-Founder & Member of Scientific Advisory Board

Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc. Структура на управлението

Информация за управлението